Vagus nerve stimulation for ME/CFS

ME/CFS and the vagus nerve

ME/CFS involves profound fatigue, post-exertional malaise (PEM), and a nervous system that many patients describe as chronically stuck in the wrong gear — which is why vagus nerve stimulation gets explored here, but why this community also has some of the most serious, well-documented cases of things going wrong when it's approached carelessly.

What users report: a real success story, a real disaster, and a real scam scare that wasn't

The most detailed positive account we found came from someone who tried three different devices before settling on Sensate, and was specific enough to be genuinely useful: their Oura-tracked HRV had been declining steadily for months, from the 60s and 70s down into the 30s and 40s, before rising back to the 50s-70s range within the first two days of consistent nightly Sensate use and holding there. They'd tried Nurosym first and found the tragus clip fussy and unreliable — needing to keep re-wetting the contact and restart the device each time — before moving to Sensate specifically for its lower hassle. That kind of detail (specific before/after numbers, specific reasons for switching devices) is more useful than a vague "it helped."

Set directly against that is one of the more serious individual accounts in our whole corpus: a user who started Nurosym at 30 minutes twice a day — already longer than most cautious protocols recommend — developed worsening fatigue, was told by the company to cut down to 15 minutes twice daily, but two days later developed severe dizziness bad enough that they could barely stand, lasting more than a week after stopping the device entirely. They were candid that they wished someone had warned them how strong a reaction this could trigger. This is a genuinely serious report, and it's also a report where the person had, by their own account, started at an intensity and duration well above the cautious end of what this community generally recommends — a pattern worth taking as a real warning about starting protocol, not proof that any use of any device carries this risk.

Separately, one detailed "Nurosym is a scam" post is worth reading for how it actually resolved, because the headline is misleading: after a frustrating initial silence, the company did process a refund, and the poster explicitly updated their own post to say the company appeared legitimate — their complaint was that it didn't work for their ME/CFS specifically, not that they'd been defrauded. Buried in the same thread was a substantive, well-informed technical objection worth taking seriously on its own terms: that the tragus (Nurosym's stimulation site) lacks strong, settled evidence of dense vagal innervation compared to the cymba concha, and that clinical trial results at the tragus specifically have been mixed — the same anatomical debate we cover in our Nurosym vs Zenowell comparison.

What the specialist ME/CFS forums add, beyond Reddit

Phoenix Rising and Health Rising — two forums run for and by the ME/CFS community specifically, some moderated by clinicians and long-time patient-advocates — carry a longer, more specific thread of device history than most Reddit posts, precisely because a handful of members have tracked their use for years. Two Nurosym reports there are worth reading side by side. One member bought the device after weighing it against riskier options (antivirals, immunosuppressants) and, after 57 days of consistent use, reported plainly: no improvement in any of the symptoms it's marketed for — digestion, fatigue, insomnia, depression, anxiety, cognitive dysfunction. Another member ran their own two-month tracked trial and concluded the Nurosym had no discernible effect on their IBS "except on my bank account" — but added an important caveat: they were also doing daily breathing exercises and taking medication with a clear, tracked effect on their autonomic nervous system, so the device might have done more before those other changes were already covering the same ground.

Set against those two null results, one member's account of the Amofit S+ (a lesser-known taVNS device) stood out for its specificity: concentration improved, brain fog "disappeared," and they described being able to read, listen to music and watch films again after months of not being able to, alongside regained muscle strength and less dizziness. A separate small, informal comparison from a Norwegian ME/CFS support group tracked three people trying two different devices: two who used a NeuroTrac TENS-based unit were pleased (one saw her POTS-related heart rate drop from 120-130 to 80-100 bpm), while the person using a different CES-style device (marketed for cranial stimulation, adapted for vagal use) felt no difference — a small sample, but a useful illustration of how device and individual both seem to matter.

One detail worth flagging for anyone assembling a DIY setup: a forum member with a biochemistry background who works in an integrative pain clinic laid out specific parameters gathered from published tVNS research — 20-30 Hz frequency, 200-500 microsecond pulse width, electrode at the tragus with a drop of saline for conductivity, and crucially, intensity set only to where you can just feel it, or slightly below. They noted that people they knew personally who cranked the intensity up higher, assuming more would be better, ended up with headaches instead of benefit — direct, practical evidence for why "start low" isn't just a generic caution here.

Why your wearable's numbers might not match how you feel

A separate, very common frustration in this community deserves its own mention because it applies whether or not you ever try a device: people describe crashes where their heart rate, breathing regularity and HRV all look fine or even good on their tracker, while they feel unmistakably terrible. One detailed account described exactly this — an Oura ring showing HRV above their own baseline during a crash, which the app flagged as a stress signal despite being numerically "higher," while blood pressure and subjective symptoms told a completely different story. If you're using a wearable to judge whether vagal stimulation is helping your ME/CFS, be prepared for the numbers and how you feel to disagree — and don't let a good-looking chart talk you out of what your body is telling you, or vice versa.

A safety note for ME/CFS

This is very likely the group most vulnerable to a crash from over-doing it, and the case above — 30 minutes twice daily, followed by a week-plus of severe dizziness — is a real illustration of why starting cautiously matters more here than almost anywhere else on this site. Start with the shortest, lowest session imaginable (5 minutes, once daily, is a commonly recommended starting point in ME/CFS-focused discussions, well below many devices' default protocols), leave long gaps between early sessions, and stop at the first sign of PEM rather than pushing through it. See side effects & safety before starting.

Learn more

New here? Start with the complete guide and the Glossary. For the device itself, see our Nurosym review.

Frequently asked questions

Can vagus nerve stimulation help ME/CFS?

A minority report slow gains over weeks of gentle use, but the evidence is anecdotal and the crash risk is real. Any trial should be extremely cautious.

Why is the crash risk higher in ME/CFS?

Post-exertional malaise means stimulation can act as a trigger. Starting too high or too long can worsen symptoms for days.

Should I use a cheap TENS for this?

Only with extreme caution, if at all. Wrong settings raise the risk. Read the safety guide and consider the bounded parameters of a purpose-built device.

Why might my wearable show good numbers during a crash?

Metrics like HRV and resting heart rate don't always track how a crash actually feels, and can even look better than baseline during one. Trust your symptoms over a single reassuring or alarming number.

What do specialist ME/CFS forums say beyond Reddit?

Phoenix Rising and Health Rising members who tracked use for months report a genuine mix: two detailed null results on Nurosym (57 days and 2 months of tracked use with no benefit), one detailed positive account of the Amofit S+ (concentration and brain fog improved over months), and a small informal comparison where 2 of 3 people benefited from a TENS-based device while one felt nothing on a different one.